🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
63.62
-1.36 (-2.09%)
Nov 20, 2026, 4:00 PM EST - Market closed

Corcept Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
963.65761.41675.04482.38401.86365.98
Revenue Growth
30.02%12.79%39.94%20.04%9.80%3.42%
Cost of Revenue
14.112.9810.886.485.395.28
Gross Profit
949.55748.43664.16475.89396.47360.7
Selling, General & Admin
596.92448.73280.32184.26152.85122.36
Research & Development
241.72254.91246.89184.35130.99113.86
Operating Expenses
838.64703.63527.21368.61283.84236.22
Operating Income
110.9144.8136.95107.28112.63124.48
Interest & Investment Income
20.5221.6724.5417.283.560.53
Legal Settlements
-----14-
Pretax Income
131.4366.46161.49124.56116.19125.01
Income Tax Expense
-30.86-33.1920.2818.4214.7712.49
Net Income
162.2999.65141.21106.14101.42112.51
Preferred Dividends & Other Adjustments
2.931.481.480.640.13-
Net Income to Common
159.3698.17139.73105.5101.29112.51
Net Income Growth
52.27%-29.74%32.45%4.15%-9.98%6.13%
Shares Outstanding (Basic)
105104103104107116
Shares Outstanding (Diluted)
120120113112116126
Shares Change
-0.19%5.73%1.55%-3.64%-7.94%1.42%
EPS (Basic)
1.520.951.351.020.950.97
EPS (Diluted)
1.330.821.230.940.870.89
EPS Growth
52.19%-33.33%30.85%8.05%-2.25%4.71%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
194.62141.79196.12126.54119.91167.42
Free Cash Flow Per Share
1.631.181.731.131.031.33
Gross Margin
98.54%98.30%98.39%98.66%98.66%98.56%
Operating Margin
11.51%5.88%20.29%22.24%28.03%34.01%
Profit Margin
16.54%12.89%20.70%21.87%25.20%30.74%
Free Cash Flow Margin
20.20%18.62%29.05%26.23%29.84%45.75%
EBITDA
113.1445.95137.75108.32113.89125.96
EBITDA Margin
11.74%6.03%20.41%22.46%28.34%34.42%
D&A For EBITDA
2.231.150.81.041.261.48
EBIT
110.9144.8136.95107.28112.63124.48
EBIT Margin
11.51%5.88%20.29%22.24%28.03%34.01%
Effective Tax Rate
--12.56%14.79%12.71%9.99%
SEC Filings: 10-K · 10-Q